May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Epidermal Growth Factor Induces C–Fos Expression and Wound Closure in Human Corneal Epithelial Cell Line
Author Affiliations & Notes
  • Y. Okada
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • S. Saika
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • K. Shirai
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • O. Yamanaka
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • Y. Ohnishi
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • P.S. Reinach
    Optmetry, State University of New York, New York, NY
  • Footnotes
    Commercial Relationships  Y. Okada, None; S. Saika, None; K. Shirai, None; O. Yamanaka, None; Y. Ohnishi, None; P.S. Reinach, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5044. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Okada, S. Saika, K. Shirai, O. Yamanaka, Y. Ohnishi, P.S. Reinach; Epidermal Growth Factor Induces C–Fos Expression and Wound Closure in Human Corneal Epithelial Cell Line . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5044.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To identify the upstream mediators that affect prolonged activation of c–fos in response to EGF during wound healing in a human corneal epithelial cell line (HCE), we applied different siganling inhibitors to the HCE cell culture. We previously demonstrated that AP–1 components, c–fos/c–jun, are up–regulated in healing rat corneal epithelium in relatively early phase following epithelial debridement.

Methods: : A linear epithelial defect was produced in a HCE monolayer. Healing kinetics were evaluated in presence and absence of the following selective inhibitors: 1) JNK inhibitor 1, (JNK); 2) SB203580, (p38); 3) UO126, (Erk1/2); 4) AG1478, (EGF receptor); 5) U71322 (PLC) 6) LY294002 (PI–3 kinase) with or without EGF (10ng/ml). Moreover, these HCE monolayers were immunohistochemically stained with c–Fos antibody.

Results: : EGF promoted wound closure and up–regulated c–Fos protein expression. Each inhibitor decreased defect healing in HCE culture. Inhibition of p38 MAPK signaling suppressed healing more than any of the aforementioned other inhibitors. The rank order of inhibition was: p38 > JNK > EGF receptor > Erk1/2 > PI–3 kinase > PLC. Only Erk1/2 inhibitor suppressed c–Fos protein expression.

Conclusions: : Blocking Erk1/2 activation by treatment with U0126 suppressed wound closure and c–Fos protein expression. MAP kinase/Erk–deriven c–Fos/AP–1 signal might have a critical role in corneal epithelial wound healing

Keywords: cornea: basic science • growth factors/growth factor receptors • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×